Daniel M Hartung

15PUBLICATIONS
25CO-AUTHORS
OptometryGene and molecular therapyPricing (incl. consumer value estimation)Primary health careToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 11, 2026
Opioid use disorder medication treatment in residential settings increased 2017-2021, but sustaining it following stays remains an issue.

|Feb 19, 2026
Changes in List and Net Prices for Multiple Sclerosis Disease-Modifying Therapy, 2013 to 2021.

Daniel M Hartung, Nico Gabriel, Walid F Gellad

|Jan 08, 2025
Industry Payments and Branded Glatiramer Acetate Prescribing in the US Medicare Program.

Daniel M Hartung, Sheila Markwardt, Dennis Bourdette

|Jun 05, 2024
Effect of integration of prescription drug monitoring program data in the electronic health record on queries by primary care providers.

Daniel M Hartung, Steven Z Kassakian, Michelle A Hendricks

|Jan 10, 2023
Sedative-hypnotic Co-prescribing with Opioids in a Large Network of Community Health Centers.

Daniel M Hartung, Jennifer A Lucas, Nathalie Huguet

|Sep 26, 2022
Association Between Pharmacy Benefit Restrictions and Disease-Modifying Therapy Use in the Medicare Part D Program.

Daniel M Hartung, Kirbee A Johnston, Jessina C McGregor

Pageof 3

Frequent Collaborators

2 joint publications

Dennis Bourdette

1 joint publications

Traci C Green

1 joint publications

Jeffrey Bratberg

1 joint publications

Adriane N Irwin